GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
Rate at Which Children Orphaned From Drug Overdose Doubles in 10 Years
A stunning new inter-agency report estimates 321,566 children lost a parent to drug overdose in 10 years.
Semaglutide As Potential Addiction Therapy
Recently, there has been growing interest in another possible use for GLP-1 weight loss and diabetes drugs — to treat addiction.
Addiction and the Difference Between Liking and Wanting
Research into the origins of addictive behavior finds it’s the brain, not the substance, that sets the hook.
More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
Where Is the Brain’s Reward System and How Does It Work?
Two studies involving brain scans attempt to map out the brain’s reward system.